Login / Signup

Efficacy of rasagiline monotherapy for early Parkinson disease: A systematic review and meta-analysis of randomized controlled trials.

Hao-Yun ChangYing-Yu LiChien-Tai HongYi-Chun Kuan
Published in: Journal of psychopharmacology (Oxford, England) (2022)
Rasagiline monotherapy at 1 mg per day is recommended for patients with early PD because of the benefits for motor, nonmotor functions, and safety.
Keyphrases
  • parkinson disease
  • deep brain stimulation
  • combination therapy
  • open label
  • systematic review
  • randomized controlled trial
  • clinical trial